These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6883288)

  • 1. Fluoresceinated estrone binding by cells from human breast cancers obtained by needle aspiration.
    Gunduz N; Zheng S; Fisher B
    Cancer; 1983 Oct; 52(7):1251-6. PubMed ID: 6883288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of estrogen receptor (ER) from needle aspirate in breast cancer cells].
    Zheng S
    Zhonghua Zhong Liu Za Zhi; 1985 Sep; 7(5):348-50. PubMed ID: 4092576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrelation between tumor cell proliferation and 17-fluoresceinated estrone binding following primary tumor removal, radiation, cyclophosphamide, or tamoxifen.
    Fisher B; Gunduz N; Saffer EA
    Cancer Res; 1983 Nov; 43(11):5244-7. PubMed ID: 6616461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescent cytochemical detection of estrogen and progesterone receptors in breast fine-needle aspirates.
    Masood S
    Am J Clin Pathol; 1991 Jan; 95(1):35-40. PubMed ID: 1987750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estradiol and progesterone receptor levels in human breast cancer in relation to cytosol and plasma estrogen level.
    Drafta D; Prişcu A; Neacşu E; Gangură M; Schindler AE; Stroe E; Anghel C; Panaitescu G
    J Steroid Biochem; 1983 Apr; 18(4):459-63. PubMed ID: 6834830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of monoclonal antibody for assessment of estrogen receptor content in fine-needle aspiration biopsy specimen from patients with breast cancer.
    Masood S
    Arch Pathol Lab Med; 1989 Jan; 113(1):26-30. PubMed ID: 2462858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor determination in fine needle aspirates of the breast. Correlation with histologic grade and comparison with biochemical analysis.
    Lozowski MS; Mishriki Y; Chao S; Grimson R; Pai P; Harris MA; Lundy J
    Acta Cytol; 1987; 31(5):557-62. PubMed ID: 3314302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor analysis on biopsies and fine-needle aspirates from human breast carcinoma. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.
    Reiner A; Spona J; Reiner G; Schemper M; Kolb R; Kwasny W; Függer R; Jakesz R; Holzner JH
    Am J Pathol; 1986 Dec; 125(3):443-9. PubMed ID: 3541638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of histochemical and biochemical assays for estrogen receptor in human breast cancer cell lines.
    Parl FF; Wetherall NT; Halter S; Schuffman S; Mitchell WM
    Cancer Res; 1984 Jan; 44(1):415-21. PubMed ID: 6690057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of ER-ICA and enzyme immunoassay for the quantitation of estrogen receptors in breast cancer.
    Hanna W; Mobbs BG
    Am J Clin Pathol; 1989 Feb; 91(2):182-6. PubMed ID: 2464923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preoperative immunocytochemical estrogen receptor determination in fine needle aspirates in breast cancer using monoclonal antibodies].
    Kübler HC; Kühn W; Rummel HH; Krapfl E; Klinga K
    Geburtshilfe Frauenheilkd; 1988 Nov; 48(11):763-7. PubMed ID: 3234709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fixation of fluorescent estrone derivative on human breast cancer cells. Correlation with age, menopause status and histopathology].
    Baltali E; Souadka A; el Hafed A; Wydadi M; Kettani F; Alamy H; el Gueddari B; Morchid M; Bouih A; Souadka F
    Bull Cancer; 1990; 77(4):363-9. PubMed ID: 2354252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor enzyme immunoassay in fine-needle aspirates from human breast cancer.
    Borg A; Fernö M; Idvall I
    Acta Oncol; 1989; 28(2):187-91. PubMed ID: 2660861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor immunocytochemistry for preoperative determination of estrogen receptor status on fine-needle aspirates of breast cancer.
    Reiner A; Reiner G; Spona J; Teleky B; Kolb R; Holzner JH
    Am J Clin Pathol; 1987 Oct; 88(4):399-404. PubMed ID: 3661495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing estrogen and progesterone receptor status in fine needle aspirates from breast carcinomas. Results on six years of material and correlation with biochemical assay.
    Sauer T; Beraki E; Jebsen PW; Amlie E; Harbitz T; Kåresen R; Naess O
    Anal Quant Cytol Histol; 1998 Apr; 20(2):122-6. PubMed ID: 9569969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoresceinated estrone binding by human and mouse breast cancer cells.
    Fisher B; Gunduz N; Zheng S; Saffer EA
    Cancer Res; 1982 Feb; 42(2):540-9. PubMed ID: 7055802
    [No Abstract]   [Full Text] [Related]  

  • 17. [Estrogen receptor (ER) of breast cancer cells. II. Quantitative analysis of breast cancer cells bound with fluoresceinate-ER].
    Zheng S
    Zhonghua Zhong Liu Za Zhi; 1986 Mar; 8(2):96-9. PubMed ID: 3769750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A relationship between estrogen sulfurylation and estrogen and progesterone receptor status in human mammary carcinoma.
    Pewnim T; Adams JB; Ho KP
    Cancer Res; 1980 Apr; 40(4):1360-2. PubMed ID: 6928401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrone receptor formation during the processing of estradiol-receptor complex in MCF-7 cells.
    Hansen ER; Brooks SC
    Cancer Res; 1982 May; 42(5):1967-74. PubMed ID: 7066908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunodetection of estrogen receptor and 52,000-dalton protein in fine needle aspirates of breast cancer tumors.
    Cavailles V; Garcia M; Salazar G; Domergue J; Simony J; Pujol H; Rochefort H
    J Natl Cancer Inst; 1987 Aug; 79(2):245-52. PubMed ID: 2439733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.